Catheter Precision, Inc. 8-K

What Happened

• Catheter Precision, Inc. announced on December 31, 2025 that it entered into Second Amendments to its outstanding 8% Short Term Promissory Notes, extending their maturity dates. The amendments affect notes totaling $1.5 million in principal that previously had amended maturities of January 31, 2026.
• New maturities: four notes (totaling $1.0 million issued to FatBoy Capital, L.P. and $500,000 issued to David A. Jenkins) were extended to January 31, 2029; one $500,000 note issued to the Jenkins Family Charitable Institute was extended to January 31, 2028. The original issue dates range from May–July 2024.

Key Details

• Total principal extended: $1,500,000 (five notes).
• Interest rate on the notes: 8% (Short Term Promissory Notes).
• Amendment date: December 31, 2025; previous amended maturity date: January 31, 2026.
• Related parties: David A. Jenkins (Executive Chair & CEO) is a holder and is affiliated with FatBoy Capital, L.P.; the Jenkins Family Charitable Institute is also a holder. The company disclosed these related-party relationships and other ties (e.g., family member in COO role and Jenkins’ royalty and option interests).

Why It Matters

• For investors, the extensions push near-term cash obligations out of 2026, easing immediate repayment pressure and affecting the company’s short-term liquidity profile and debt timeline.
• Because several holders are related to the CEO, these are related‑party transactions; investors should note potential governance and related‑party considerations when assessing company financing and capital structure.
• The filing documents the amended agreements but does not disclose other changes (e.g., increases in interest or principal). Investors seeking further detail on terms should review the filed amendments in the 8-K.